TY  - GEN
AU  - Tabernero,Josep
AU  - Chiorean,E Gabriela
AU  - Infante,Jeffrey R
AU  - Hingorani,Sunil R
AU  - Ganju,Vinod
AU  - Weekes,Colin
AU  - Scheithauer,Werner
AU  - Ramanathan,Ramesh K
AU  - Goldstein,David
AU  - Penenberg,Darryl N
AU  - Romano,Alfredo
AU  - Ferrara,Stefano
AU  - Von Hoff,Daniel D
TI  - Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
SN  - 1549-490X
PY  - 2015///1204
KW  - Adult
KW  - Aged
KW  - Albumins
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Liver Neoplasms
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Paclitaxel
KW  - Pancreatic Neoplasms
KW  - Prognosis
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1634/theoncologist.2014-0394
ER  -